Cited by 135Sleep and related disordersMenopause: Health Impacts and TreatmentsSexual function and dysfunction studies

Eszopiclone in Patients With Insomnia During Perimenopause and Early Postmenopause: A Randomized Controlled Trial

Soares, Claudio N., Joffe, Hadine, Rubens, Robert, Caron, Judy, Roth, Thomas, Cohen, Lee·2006·Obstetrics & Gynecology

Abstract

OBJECTIVE: To evaluate eszopiclone 3 mg for treatment of insomnia in perimenopausal and early postmenopausal women, as well as the impact of insomnia treatment on mood, menopause-related symptoms, and quality of life. METHODS: This was a double-blind, placebo-controlled study with 410 women (aged 40-60; perimenopausal or early postmenopausal) who reported insomnia defined as sleep latency of at least 45 minutes and total sleep time less than or equal to 6 hours per night for at least 3 nights per week over the previous month. Patients were randomly assigned to eszopiclone 3 mg or placebo nightly for 4 weeks. Sleep data were collected once a day. Physician global assessments of menopause, menopause-specific questionnaire, Greene Climacteric Scale, the Montgomery Asberg Depression Rating Scale, and the Sheehan Disability Scale were collected at baseline and end of treatment. RESULTS: Patients receiving eszopiclone reported improvements in sleep induction, sleep maintenance, sleep duration, sleep quality, and next-day functioning relative to placebo (P<.05). Patients receiving eszopiclone reported fewer total awakenings and awakenings due to hot flushes (P<.05). Eszopiclone use led to greater improvement in Montgomery Asberg Depression Rating Scale scores (P<.05) and physician global assessments of menopause scores (P<.001); total Greene Climacteric Scale score and the vasomotor and psychological sub-scores (P<.05); vasomotor and physical domains of the menopause-specific questionnaire (P<.05); and family life/home domain of the Sheehan Disability Scale (P<.05). CONCLUSION: In this study, eszopiclone provided significant improvements in sleep and positively impacted mood, quality of life, and menopause-related symptoms in perimenopausal and early postmenopausal women with insomnia. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov www.clinicaltrials.gov NCT00366093 LEVEL OF EVIDENCE: I.

Integrity signals

Registry

Crossref · 10.1097/01.aog.0000245449.97365.97

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Zolpidem and eszopiclone have been shown to be more effective than placebo in the treatment of insomnia in the early stages of menopause.

    “although zolpidem and eszopiclone have been shown to be more effective than a placebo in the treatment of insomnia in the early stages of menopause [127-129]”

    From Non-Pharmacological Treatment of Insomnia (2012) · cites this paper as [129]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Soares, C. N., Joffe, H., Rubens, R., Caron, J., Roth, T., & Cohen, L.
Affiliations
  • Harvard University (US)
  • Sunovion (United States) (US)
  • Henry Ford Health (US)
Venue
Obstetrics & Gynecology
Published
2006-12
Volume
108
Issue
6
Pages
1402-1410
ISSN
0029-7844 (ISSN-L)
OpenAlex
W2324394935
Cited by
135
References
26
Citations by year
2026: 5 · 2025: 2 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 2 · 2014: 9 · 2013: 16 · 2012: 7
FWCI
13.40
Type
journal article
Language
en
Open access
closed
Locations
  • Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Keywords
eszopiclone, insomnia, perimenopause, early postmenopause, menopausal symptoms, hot flashes, sleep quality, mood, depression, quality of life, sleep latency, sleep maintenance, sleep duration, sleep awakenings
MeSH terms
Affect, Double-Blind Method, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Middle Aged, Piperazines, Quality of Life, Sleep, Postmenopause, Hot Flashes, Perimenopause, Azabicyclo Compounds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review